Immunis Inc

Immunis is a private biotechnology company developing human cell-derived secretomes to address age-related diseases and immune dysfunction. We created a novel method of isolating clinical-grade secreted cellular factors (the secretome), which has preclinical efficacy in benefiting immune system development and modulation, as well as metabolism and muscle health. Our Phase 1/2a clinical trial measures the safety/efficacy of the secretome in reversing muscle atrophy in elderly individuals.